Summary & Overview
HCPCS Level II A4544: Electrode for External Lower Extremity Nerve Stimulator for Restless Legs Syndrome
HCPCS Level II code A4544 designates an electrode component for external lower-extremity nerve stimulators used to treat restless legs syndrome. The code matters nationally as coverage and reimbursement for device components affects access to adjunctive symptomatic therapies for a common neurologic sleep-related movement disorder. Clarity on coding enables consistent billing for suppliers, durable medical equipment programs, and outpatient therapy providers who support neuromodulation-based symptom management.
Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical purpose, typical sites of service, and the service type. The publication also summarizes payer coverage patterns and benchmark considerations where available, highlights relevant policy updates that impact billing for device components, and situates A4544 within clinical practice for restless legs symptom management. Practical details include common modifier guidance and the context for suppliers and clinicians to align documentation and claims submission.
Data not available in the input for associated taxonomies, specific ICD-10 pairings, and related billing lines.
Billing Code Overview
HCPCS Level II code A4544 describes an electrode for external lower extremity nerve stimulator for restless legs syndrome. This item is a durable medical device component used to deliver transcutaneous electrical stimulation specifically targeted at lower-extremity nerves to address symptoms of restless legs syndrome.
Service Type: Durable medical equipment accessory / external nerve stimulation
Typical Site of Service: Outpatient clinic, physician office, home use (durable medical equipment accessory)
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting with worsening symptoms of restless legs syndrome (RLS) characterized by an uncontrollable urge to move the legs, often accompanied by paresthesia and nocturnal exacerbation that interferes with sleep and daily function. The patient has tried first-line medical therapy (iron repletion when indicated, dopaminergic agents, gabapentin/pregabalin) with incomplete response or intolerable side effects. A neurology or sleep medicine specialist evaluates the patient in an outpatient clinic and determines that adjunctive external lower extremity nerve stimulation may provide symptomatic relief.
The clinical workflow: the clinician documents RLS severity, prior therapies, and rationale for neuromodulation. The clinic supplies or fits the patient with one or more external electrodes (A4544) placed on the lower legs near target peripheral nerves (e.g., superficial peroneal, saphenous or tibial distributions) connected to an external nerve stimulator. Device education includes electrode placement, skin prep, stimulation parameters, safety, and home use instructions. Follow-up visits assess symptom reduction, skin integrity at electrode sites, device tolerance, and need for replacement electrodes or device reprogramming. Typical sites of service are outpatient neurology or sleep clinic, durable medical equipment (DME) supplier visits, and home use by the patient.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |